Menactra May Require More Data For Approval, Advisory Committee Chair Says

"There are a number of issues" related to the meningococcal conjugate vaccine, committee chair Overturf tells National Vaccine Advisory Committee. Sanofi-Aventis says it has not submitted any additional data to FDA on Menactra.